AMX0035 and Progressive Supranuclear Palsy

PHASE2/PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

December 21, 2023

Primary Completion Date

April 1, 2026

Study Completion Date

November 30, 2029

Conditions
Progressive Supranuclear PalsyPSPNeurodegenerative DiseasesAtypical Parkinsonism
Interventions
DRUG

AMX0035

Proprietary formulation of sodium phenylbutyrate and taurursodiol

OTHER

Placebo

Matching Placebo Comparator

Trial Locations (62)

168

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma

185

Azienda Ospedaliera Universitaria Policlinico Umberto I - Università di Roma La Sapienza, Roma

1307

Universitaetsklinikum Carl Gustav Carus TU Dresden, Dresden

7646

Asklepios Fachklinikum Stadtroda, Stadtroda

8036

Hospital Clinic de Barcelona, Barcelona

13385

Hôpital de la Timone, Marseille

19107

Pennsylvania Hospital, Philadelphia

20122

Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico, Milan

20133

Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan

28006

Hospital Universitario de La Princesa, Madrid

28034

Hospital Universitario Ramon y Cajal, Madrid

29425

Medical University of South Carolina (MUSC), Charleston

30029

Hopital Caremeau, Nîmes

30076

Groupe Hospitalier Pellegrin - Hôpital Pellegrin, Bordeaux

30912

Augusta University, Augusta

31008

Clinica Universidad de Navarra, Pamplona

32224

Mayo Clinic Florida, Jacksonville

32608

UF Health Dorothy Mangurian Neuroimaging Suite, Gainesville

33486

Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton

34128

Paracelsus-Elena-Klinik Kassel, Kassel

35033

CHU Rennes - Hopital Pontchaillou, Rennes

35128

Azienda Ospedale-Università di Padova, Padua

37232

Vanderbilt University Medical Center, Nashville

38157

Veracity Neuroscience, LLC, Memphis

41013

Hospital Universitario Virgen del Rocio, Seville

44195

The Cleveland Clinic Foundation, Cleveland

45219

University of Cincinnati, Cincinnati

46026

Hospital Universitari i Politecnic La Fe, Valencia

48334

Quest Research Institute, Farmington Hills

48903

Hospital de Cruces, Barakaldo

55414

University of Minnesota, CTSI, Minneapolis

55905

Mayo Clinic - Rochester, Rochester

59037

Hopital Roger Salengro - CHU Lille, Lille

60611

Northwestern University PD and Movement Disorders Center, Chicago

66160

University of Kansas Medical Center Research Institute, Inc., Kansas City

70121

Ochsner Medical Center, New Orleans

72205

University of Arkansas for Medical Sciences, Little Rock

75013

Groupe Hospitalier Pitie-Salpetriere, Paris

75231

Kerwin Medical Center, Dallas

77030

Baylor College of Medicine, Houston

78681

Central Texas Neurology Consultants, Round Rock

80045

UC Health Anschutz Outpatient Pavilion Anschutz Medical Campus, Aurora

83734

Krankenhaus Agatharied, Hausham

84108

University of Utah Movement Disorders Center, Salt Lake City

84131

Azienda Ospedaliera Universitaria OO. RR. S. Giovanni di Dio e Ruggi D'Aragona, Salerno

85259

Mayo Clinic, Scottsdale

87042

CHU de Limoges - Hôpital Dupuytren, Limoges

89081

Universitaetsklinikum Duesseldorf AoeR, Ulm

Universitaetsklinikum Ulm, Ulm

89106

Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas

90033

University of Southern California, Los Angeles

90048

Cedars Sinai Medical Center, Los Angeles

92708

Parkinson's & Movement Disorder Institute, Fountain Valley

94158

University of California, San Francisco (UCSF), San Francisco

94304

Stanford Movement Disorder Center, Palo Alto

96813

Parkinsons and Movement Disorder Center at the Queens Medical Center, Honolulu

97239

Oregon Health & Science University, Portland

40536-0274

University of Kentucky Medical Center, Lexington

02114

Massachusetts General Hospital, Boston

01805

Lahey Hospital and Medical Center, Burlington

23298-0059

Virginia Commonwealth University Department of Neurology, Richmond

Unknown

Klinikum der Universität München, Munich

Sponsors
All Listed Sponsors
lead

Amylyx Pharmaceuticals Inc.

INDUSTRY